TP53 mutations have been also implicated in glycan metabolism, where expression of STn and Tp53 proteins was correlative in a bladder-cancer mouse model [44] and N-glycosylated protein stability was regulated via a UDPase (ENTPD5) as a mutant Tp53 target [45]. Here, EEF1A2 is linked to urinary bladder cancer.